RUANYUN EDAI TECHNOLOGY INC (RYET) Fundamental Analysis & Valuation

NASDAQ:RYET • KYG7710T1058

Current stock price

1.02 USD
+0.01 (+0.99%)
Last:

This RYET fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. RYET Profitability Analysis

1.1 Basic Checks

  • RYET had negative earnings in the past year.
  • RYET had a negative operating cash flow in the past year.
RYET Yearly Net Income VS EBIT VS OCF VS FCFRYET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 2M -2M

1.2 Ratios

  • With a Return On Assets value of -17.25%, RYET is not doing good in the industry: 71.23% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -17.25%
ROE N/A
ROIC N/A
ROA(3y)-19.95%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RYET Yearly ROA, ROE, ROICRYET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 200 -200 -400 -600 -800

1.3 Margins

  • With a Gross Margin value of 51.17%, RYET perfoms like the industry average, outperforming 57.53% of the companies in the same industry.
  • In the last couple of years the Gross Margin of RYET has grown nicely.
  • The Profit Margin and Operating Margin are not available for RYET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 51.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.91%
GM growth 5YN/A
RYET Yearly Profit, Operating, Gross MarginsRYET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. RYET Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for RYET remains at a similar level compared to 1 year ago.
  • RYET has a worse debt/assets ratio than last year.
RYET Yearly Shares OutstandingRYET Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M
RYET Yearly Total Debt VS Total AssetsRYET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of 0.48, we must say that RYET is in the distress zone and has some risk of bankruptcy.
  • RYET has a Altman-Z score of 0.48. This is in the lower half of the industry: RYET underperforms 60.27% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACCN/A
WACCN/A
RYET Yearly LT Debt VS Equity VS FCFRYET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 2M -2M

2.3 Liquidity

  • RYET has a Current Ratio of 0.67. This is a bad value and indicates that RYET is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of RYET (0.67) is worse than 79.45% of its industry peers.
  • A Quick Ratio of 0.66 indicates that RYET may have some problems paying its short term obligations.
  • RYET has a Quick ratio of 0.66. This is in the lower half of the industry: RYET underperforms 76.71% of its industry peers.
Industry RankSector Rank
Current Ratio 0.67
Quick Ratio 0.66
RYET Yearly Current Assets VS Current LiabilitesRYET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 2M 4M 6M 8M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. RYET Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 70.95% over the past year.
  • The Revenue for RYET has decreased by -30.03% in the past year. This is quite bad
  • Measured over the past years, RYET shows a very negative growth in Revenue. The Revenue has been decreasing by -19.47% on average per year.
EPS 1Y (TTM)70.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.13%
Revenue 1Y (TTM)-30.03%
Revenue growth 3Y-19.47%
Revenue growth 5YN/A
Sales Q2Q%-26.97%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RYET Yearly Revenue VS EstimatesRYET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2M 4M 6M 8M 10M

More info and screens

Find the best growth stocksShow best growing peers

0

4. RYET Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RYET. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RYET Price Earnings VS Forward Price EarningsRYET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RYET Per share dataRYET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RYET Dividend Analysis

5.1 Amount

  • No dividends for RYET!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RYET Fundamentals: All Metrics, Ratios and Statistics

RUANYUN EDAI TECHNOLOGY INC

NASDAQ:RYET (3/20/2026, 8:21:43 PM)

1.02

+0.01 (+0.99%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)07-31
Earnings (Next)N/A
Inst Owners0.19%
Inst Owner ChangeN/A
Ins Owners1.69%
Ins Owner ChangeN/A
Market Cap0
Revenue(TTM)10.80M
Net Income(TTM)-1.01M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio3.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.19
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.32
BVpS0
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -17.25%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 51.17%
FCFM N/A
ROA(3y)-19.95%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y8.91%
GM growth 5YN/A
F-Score3
Asset Turnover1.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.87%
Cap/Sales 1.34%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.67
Quick Ratio 0.66
Altman-Z 0.48
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)47.47%
Cap/Depr(5y)N/A
Cap/Sales(3y)1.93%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)70.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.13%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.03%
Revenue growth 3Y-19.47%
Revenue growth 5YN/A
Sales Q2Q%-26.97%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y71.39%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-144.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-127.64%
OCF growth 3YN/A
OCF growth 5YN/A

RUANYUN EDAI TECHNOLOGY INC / RYET Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for RUANYUN EDAI TECHNOLOGY INC?

ChartMill assigns a fundamental rating of 0 / 10 to RYET.


Can you provide the valuation status for RUANYUN EDAI TECHNOLOGY INC?

ChartMill assigns a valuation rating of 0 / 10 to RUANYUN EDAI TECHNOLOGY INC (RYET). This can be considered as Overvalued.


How profitable is RUANYUN EDAI TECHNOLOGY INC (RYET) stock?

RUANYUN EDAI TECHNOLOGY INC (RYET) has a profitability rating of 1 / 10.


What is the financial health of RUANYUN EDAI TECHNOLOGY INC (RYET) stock?

The financial health rating of RUANYUN EDAI TECHNOLOGY INC (RYET) is 0 / 10.